Gene Therapy Market Size, Share & Trends Report

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Large B-cell Lymphoma, Beta-Thalassemia Major/SCD), By Vector Type (Lentivirus, AAV), By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-2-68038-179-5
  • Number of Pages: 180
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2019
  • Industry: Healthcare

Market segmentation

  • Gene Therapy Indication Outlook (Revenue, USD Million, 2017 - 2028)
    • Acute Lymphoblastic Leukemia (ALL)
    • Inherited Retinal Disease
    • Large B-Cell Lymphoma
    • ADA-SCID
    • Melanoma (lesions)
    • Beta-Thalassemia Major/SCD
    • Head & Neck Squamous Cell Carcinoma
    • Peripheral Arterial Disease
    • Spinal Muscular Atrophy (SMA) 
    • Others
  • Gene Therapy Vector Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Lentivirus
    • AAV
    • RetroVirus & gamma RetroVirus
    • Modified Herpes Simplex Virus
    • Adenovirus
    • Non-viral Plasmid Vector
  • Gene Therapy Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • North America Gene Therapy Market, By Indication
        • Acute Lymphoblastic Leukemia (ALL)
        • Inherited Retinal Disease
        • Large B-Cell Lymphoma
        • ADA-SCID
        • Melanoma (lesions)
        • Beta-Thalassemia Major/SCD
        • Head & Neck Squamous Cell Carcinoma
        • Peripheral Arterial Disease
        • Spinal Muscular Atrophy (SMA)
        • Others
      • North America Gene Therapy Market, By Vector Type
        • Lentivirus
        • AAV
        • RetroVirus & gamma RetroVirus
        • Modified Herpes Simplex Virus
        • Adenovirus
        • Non-viral Plasmid Vector
      • U.S.
        • The U.S. Gene Therapy Market, By Indication
          • Acute Lymphoblastic Leukemia (ALL)
          • Inherited Retinal Disease
          • Large B-Cell Lymphoma
          • ADA-SCID
          • Melanoma (lesions)
          • Beta-Thalassemia Major/SCD
          • Head & Neck Squamous Cell Carcinoma
          • Peripheral Arterial Disease
          • Spinal Muscular Atrophy (SMA)
          • Others
        • The U.S. Gene Therapy Market, By Vector Type
          • Lentivirus
          • AAV
          • RetroVirus & gamma RetroVirus
          • Modified Herpes Simplex Virus
          • Adenovirus
          • Non-viral Plasmid Vector
      • Canada
        • Canada Gene Therapy Market, By Indication
          • Acute Lymphoblastic Leukemia (ALL)
          • Inherited Retinal Disease
          • Large B-Cell Lymphoma
          • ADA-SCID
          • Melanoma (lesions)
          • Beta-Thalassemia Major/SCD
          • Head & Neck Squamous Cell Carcinoma
          • Peripheral Arterial Disease
          • Spinal Muscular Atrophy (SMA)
          • Others
        • Canada Gene Therapy Market, By Vector Type
          • Lentivirus
          • AAV
          • RetroVirus & gamma RetroVirus
          • Modified Herpes Simplex Virus
          • Adenovirus
          • Non-viral Plasmid Vector
    • Europe
      • Europe Gene Therapy Market, By Indication
        • Acute Lymphoblastic Leukemia (ALL)
        • Inherited Retinal Disease
        • Large B-Cell Lymphoma
        • ADA-SCID
        • Melanoma (lesions)
        • Beta-Thalassemia Major/SCD
        • Head & Neck Squamous Cell Carcinoma
        • Peripheral Arterial Disease
        • Spinal Muscular Atrophy (SMA)
        • Others
      • Europe Gene Therapy Market, By Vector Type
        • Lentivirus
        • AAV
        • RetroVirus & gamma RetroVirus
        • Modified Herpes Simplex Virus
        • Adenovirus
        • Non-viral Plasmid Vector
    • Asia Pacific
      • Asia Pacific Gene Therapy Market, By Indication
        • Acute Lymphoblastic Leukemia (ALL)
        • Inherited Retinal Disease
        • Large B-Cell Lymphoma
        • ADA-SCID
        • Melanoma (lesions)
        • Beta-Thalassemia Major/SCD
        • Head & Neck Squamous Cell Carcinoma
        • Peripheral Arterial Disease
        • Spinal Muscular Atrophy (SMA)
        • Others
      • Asia Pacific Gene Therapy Market, By Vector Type
        • Lentivirus
        • AAV
        • RetroVirus & gamma RetroVirus
        • Modified Herpes Simplex Virus
        • Adenovirus
        • Non-viral Plasmid Vector
      • China
        • China Gene Therapy Market, By Indication
          • Acute Lymphoblastic Leukemia (ALL)
          • Inherited Retinal Disease
          • Large B-Cell Lymphoma
          • ADA-SCID
          • Melanoma (lesions)
          • Beta-Thalassemia Major/SCD
          • Head & Neck Squamous Cell Carcinoma
          • Peripheral Arterial Disease
          • Spinal Muscular Atrophy (SMA)
          • Others
        • China Gene Therapy Market, By Vector Type
          • Lentivirus
          • AAV
          • RetroVirus & gamma RetroVirus
          • Modified Herpes Simplex Virus
          • Adenovirus
          • Non-viral Plasmid Vector
      • Japan
        • Japan Gene Therapy Market, By Indication
          • Acute Lymphoblastic Leukemia (ALL)
          • Inherited Retinal Disease
          • Large B-Cell Lymphoma
          • ADA-SCID
          • Melanoma (lesions)
          • Beta-Thalassemia Major/SCD
          • Head & Neck Squamous Cell Carcinoma
          • Peripheral Arterial Disease
          • Spinal Muscular Atrophy (SMA)
          • Others
        • Japan Gene Therapy Market, By Vector Type
          • Lentivirus
          • AAV
          • RetroVirus & gamma RetroVirus
          • Modified Herpes Simplex Virus
          • Adenovirus
          • Non-viral Plasmid Vector
      • Russia
        • Russia Gene Therapy Market, By Indication
          • Acute Lymphoblastic Leukemia (ALL)
          • Inherited Retinal Disease
          • Large B-Cell Lymphoma
          • ADA-SCID
          • Melanoma (lesions)
          • Beta-Thalassemia Major/SCD
          • Head & Neck Squamous Cell Carcinoma
          • Peripheral Arterial Disease
          • Spinal Muscular Atrophy (SMA)
          • Others
        • Russia Gene Therapy Market, By Vector Type
          • Lentivirus
          • AAV
          • RetroVirus & gamma RetroVirus
          • Modified Herpes Simplex Virus
          • Adenovirus
          • Non-viral Plasmid Vector
      • Australia
        • Australia Gene Therapy Market, By Indication
          • Acute Lymphoblastic Leukemia (ALL)
          • Inherited Retinal Disease
          • Large B-Cell Lymphoma
          • ADA-SCID
          • Melanoma (lesions)
          • Beta-Thalassemia Major/SCD
          • Head & Neck Squamous Cell Carcinoma
          • Peripheral Arterial Disease
          • Spinal Muscular Atrophy (SMA)
          • Others
        • Australia Gene Therapy Market, By Vector Type
          • Lentivirus
          • AAV
          • RetroVirus & gamma RetroVirus
          • Modified Herpes Simplex Virus
          • Adenovirus
          • Non-viral Plasmid Vector
    • RoW
      • RoW Gene Therapy Market, By Indication
        • Acute Lymphoblastic Leukemia (ALL)
        • Inherited Retinal Disease
        • Large B-Cell Lymphoma
        • ADA-SCID
        • Melanoma (lesions)
        • Beta-Thalassemia Major/SCD
        • Head & Neck Squamous Cell Carcinoma
        • Peripheral Arterial Disease
        • Spinal Muscular Atrophy (SMA)
        • Others
      • RoW Gene Therapy Market, By Vector Type
        • Lentivirus
        • AAV
        • RetroVirus & gamma RetroVirus
        • Modified Herpes Simplex Virus
        • Adenovirus
        • Non-viral Plasmid Vector

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.